Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

BMP2/BMP6/activin A-based chimera for bone repair

April 30, 2019 8:15 PM UTC

INDICATION: Bone repair

Cell culture and non-human primate studies identified chimera composed of BMP2, BMP6 and activin A sequences that could help repair bone.The chimera consists of human BMP2 engineered with substitutions of amino acid sequences from human BMP6 and receptor-binding domains of human activin A. In mouse myoblasts, the chimera increased alkaline phosphatase activity, a marker of early stage osteoblast differentiation, compared with BMP2. In human periosteal-derived stem cells, the chimera increased alkaline phosphatase activity and mineralization, a marker of late stage osteoblast differentiation. In a macaque model of fibula ostectomy, the chimera delivered to the fracture site with calcium-deficient hydroxyapatite granules suspended in a recombinant human collagen type I (COL1) matrix increased bone remodeling compared with the granule-COL1 matrix alone. In two baboon models of fibula ostectomy, the chimera plus the granule-COL1 matrix increased bone remodeling compared with pretreatment baselines. Next steps by Bioventus Inc. include finding a partner for clinical trials of the chimera and composite matrix combination...